Partner Headlines - ESRX

  1. UPDATE: Goldman Sachs Downgrades Express Scripts Holding Company

    Benzinga
  2. Benzinga's Top Downgrades

    Benzinga
  3. Goldman Sachs Downgrades Express Scripts To Neutral

    Benzinga
  4. Air Methods Navigates To Grow Medical Flight Business

    IBD
  5. Buyback ETF Slow-Footed: Better Ideas Here

    YCharts
  6. Without Its Tax Dodge, What’s Walgreen Worth?

    YCharts
  7. The Stocks Already in Correction Mode

    FoxBusiness
  8. Shares Of Express Scripts Up 5% Following Q2 Earnings

    Benzinga
  9. Quarterly “Beats”: Bah, Here Are Real Growers

    YCharts
  10. #PreMarket Primer: Tuesday, July 29: Russia Accused Of Violating ...

    Benzinga
  11. Earnings Scheduled For July 29, 2014

    Benzinga
  12. Horizon Pharma Drugs Ditched By Pharmacies; Stock Falls

    IBD
  13. Is Walgreen Set For A Better 2014?

    GuruFocus
  14. Morning Market Losers

    Benzinga
  15. Benzinga's Top #PreMarket Losers

    Benzinga
  16. Benzinga Weekly Preview: FOMC In Focus, As Earnings Season Progresses

    Benzinga
  17. Dodge & Cox Second Quarter 2014 Commentary

    GuruFocus
  18. #PreMarket Primer: Friday, July 18: Tension Between Russia And ...

    Benzinga
  19. Walgreen Tax Inversion: Masking A Weak Business?

    YCharts
  20. Merck, Gilead Lead Race To Eradicate Hepatitis C

    IBD
  21. Mid-Year Report Part Two: Not All Stocks Overpriced

    YCharts
  22. Walgreen, Rite Aid Comp Sales Beat On Pharmacies

    IBD
  23. Market Rarity: Great Company at Very Good Price

    YCharts
  24. Weekly CEO Sells Highlight: Installed Building Products Inc, ...

    GuruFocus
  25. Novo Nordisk Raises Insulin Prices As Demand Grows

    IBD
  26. Rite Aid Lowers Outlook On Drug Costs; Shares Fall

    IBD
  27. Walgreen Soars On Bigger Baskets, Scripts In May

    IBD
  28. Standout In Pharma Supply Chain’s Growth Story

    YCharts
  29. Walgreen Shares Climb Sharply in Holiday-Lifted April

    IBD
  30. Walgreen Hits Record Close On Sweet Easter Sales

    IBD
  31. Novo Nordisk lowers outlook

    IBD
  32. Novo Nordisk Struggles In U.S. Market; Q1 Sales Miss

    IBD
  33. Market Wrap For May 1: Markets Mixed To Start The New Month

    Benzinga
  34. Novo Nordisk Q1 Revenue Misses; Guidance Lowered

    IBD
  35. CVS Retail, Buyback Expected To Boost Q1 Earnings

    IBD
  36. Nasdaq Leads Early Stock Slide; Twitter Tumbles, Trinity Rises

    IBD
  37. Morning Market Losers

    Benzinga
  38. Stock Futures Drag Toward Open; Twitter, VistaPrint Tumble

    IBD
  39. Benzinga's Top #PreMarket Losers

    Benzinga
  40. Market Wrap For April 29: Dow Approaches Record Highs Despite ...

    Benzinga
  41. #PreMarket Primer: Tuesday, April 29: US Steps Up Sanctions Against ...

    Benzinga
  42. AbbVie Beats Q1 Estimates, Downplays HCV 'Price War'

    IBD
  43. Gilead, Illumina Q1 Earnings Win Wall Street's Love

    IBD
  44. Biohazard? Gilead Leads 5 Big-Cap Biotech Earnings

    IBD
  45. UnitedHealth Earnings Drop on ObamaCare, Medicare Cuts

    IBD
  46. Funds Buying UnitedHealth: Stunning Div Growth

    YCharts
  47. House Probe Of Gilead's Sovaldi Price Hits Biotechs

    IBD
  48. Gilead Pricing Probed By House; Biotech Stocks Drop

    IBD
  49. Weekly Insider Sells Highlight: JAZZ, HD, ESRX, SCI

    GuruFocus
  50. Google, Ebay: Why A Top Mutual Fund Likes Them

    IBD
  51. Top 4 Large-Cap Stocks In The Health Care Plans Industry With ...

    Benzinga
  52. UPDATE: Morgan Stanley Reiterates on Express Scripts Following ...

    Benzinga
  53. Stock Market Erases Gains, Closes With Losses

    IBD
  54. Stocks Advance In Big Trade; Spirit, Priceline Climb

    IBD
  55. EXPRESS SCRIPTS

    IBD
  56. Earnings Scheduled For February 20, 2014

    Benzinga
  57. Morgan Stanley Feels Confident About Express Scripts Holding ...

    Benzinga
  58. Revenue Growth + Sane Valuation: Making A List

    YCharts
  59. It's Time to Follow Chris Davis and Buy Laboratory Corp

    GuruFocus
  60. Double Downside Protection: Moat + Value Pricing

    YCharts
  61. Express Scripts Names Cathy R. Smith CFO

    Benzinga
  62. Investors Stick With Health Care Stocks

    FoxBusiness
  63. McKesson, Cardinal, Amerisource Up Drug-Dealing Ante

    IBD
  64. Walgreen Hurt By Generic Drug Slowdown, Sees '14 Lift

    IBD
  65. S&P Stocks Hitting New Highs

    FoxBusiness
  66. Gilead's Next Hepatitis C Drug A Hit In Trials

    IBD
  67. UPDATE: Morgan Stanley Removes PT on Express Scripts on Management ...

    Benzinga
  68. Walgreen, Rite Aid To Get Drugstore Earnings Checkups

    IBD
  69. UPDATE: Morgan Stanley Reiterates on Express Scripts on Potential ...

    Benzinga
  70. RainTree Oncology Services Announces Distribution Agreement with ...

    Benzinga
  71. Gilead knocked on drug price

    IBD
  72. Gilead HCV Drug May Face Price War; Rival AbbVie Up

    IBD
  73. Health Care ETFs After Obamacare (IHF, XLV, UNH, ESRX)

    Benzinga
  74. RT Oncology Services Joins Express Scripts Pharmacy Network

    Benzinga
  75. ETFs to Buy During Market Pullback (FDN, IHF, GOOG, AMZN, UNH)

    Benzinga
  76. Warrior Capital's Major Sells in Review - VistaPrint, Google, ...

    GuruFocus
  77. Walgreen Takes Some Steps In New Direction

    IBD
  78. UPDATE: Deutsche Bank Initiates Coverage on Express Scripts Holding ...

    Benzinga
  79. Big Surprise While Hunting Bargains: Uncle Warren

    YCharts
  80. Stocks Rise In Mixed Trade; Deckers Outdoor Leaps On Q3 Win

    IBD
  81. Benzinga's Top #PreMarket Losers

    Benzinga
  82. Scott Black's Top 5 New Stock Buys

    GuruFocus
  83. Scott Black's Delphi Management Top 5 New Stock Buys

    GuruFocus
  84. Earnings Expectations For The Week Of October 21: The Crunch ...

    Benzinga
  85. Viagra, No Levitra: Espress Scirpts’ Ix-Nay List

    YCharts
  86. Catamaran, Express Scripts May Get ObamaCare Boost

    IBD
  87. Catamaran, Express Scripts May Get ObamaCare Boost

    IBD
  88. Express Scripts Trades Far Below Moat ETF Value

    YCharts
  89. Stocks With Moats: Which Are Cheap Right Now?

    YCharts
  90. Walgreen Tops Earnings Views, Bullish On ObamaCare

    IBD
  91. Moat Logic: Up 26% YTD, Berkshire Rated Cheaper

    YCharts
  92. Walgreen To Report Q4 Ahead of ObamaCare, Expansion

    IBD
  93. Was UnitedHealth, Insurer Stock Sell-Off Premature?

    IBD
  94. PBMs shake off Walgreen news

    IBD
  95. Walgreen's Exchange Shift May Help Catamaran, PBMs

    IBD
  96. Richard Perry - Eight Sells in Second Quarter - MGIC Up 505%

    GuruFocus
  97. Express Scripts Stays One Step Ahead Of Drug Trends

    IBD
  98. Express Scripts Beats Estimates; Lifts Outlook (ESRX)

    Benzinga
  99. EXPRESS SCRIPTS

    IBD
  100. In No-Growth Era, Screening For Growth Stocks

    YCharts
Trading Center